Updated clinical efficacy of the anti-PD-1 monoclonal antibody pembrolizumab (MK-3475) in 411 patients with melanoma Meeting Abstract


Authors: Ribas, A.; Wolchok, J. D.; Robert, C.; Kefford, R.; Hamid, O.; Daud, A.; Hwu, W. J.; Weber, J. S.; Joshua, A. M.; Gangadhar, T. C.; Patnaik, A.; Hersey, P.; Dronca, R.; Zarour, H.; Gergich, K.; Lindia, J. A.; Giannotti, M.; Li, X. N.; Ebbinghaus, S.; Kang, S. P.; Hodi, F. S.
Abstract Title: Updated clinical efficacy of the anti-PD-1 monoclonal antibody pembrolizumab (MK-3475) in 411 patients with melanoma
Meeting Title: 7th Asian Oncology Summit (AOS) and 11th Annual Conference of the Organisation for Oncology and Translational Research (OOTR)
Journal Title: European Journal of Cancer
Volume: 51
Issue: Suppl. 2
Meeting Dates: 2015 Apr 10-12
Meeting Location: Shanghai, China
ISSN: 0959-8049
Publisher: Elsevier Inc.  
Date Published: 2015-07-01
Start Page: e24
Language: English
ACCESSION: WOS:000359357900067
DOI: 10.1016/j.ejca.2015.06.072
PROVIDER: wos
Notes: Meeting Abstract: P0116 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jedd D Wolchok
    905 Wolchok